Product image of Neostigmine Methylsulfate Bp Hameln Pharma (Neostigmine Methylsulfate) supplied by GNH India

Neostigmine Methylsulfate Bp Hameln Pharma

Active Ingredient:
Neostigmine Methylsulfate
Origin:
EU

Neostigmine Methylsulfate Bp Hameln Pharma (Neostigmine Methylsulfate)

Neostigmine methylsulfate, the active ingredient in Neostigmine Methylsulfate Bp Hameln Pharma, is an acetylcholinesterase inhibitor presented as a sterile injectable for intramuscular, intravenous or subcutaneous use. It is employed to reverse non‑depolarizing neuromuscular blockade after surgery and as an adjunct in the management of myasthenia gravis.
GNH India supplies Neostigmine Methylsulfate Bp Hameln Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Hameln Pharma Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Neostigmine methylsulfate acts on the cholinergic neuromuscular system and is used in the following clinical situations:

  • Reversal of non‑depolarizing neuromuscular blockade: restores muscle strength after anesthesia.
  • Myasthenia gravis (adjunct therapy): enhances neuromuscular transmission to improve muscle function.
  • Diagnostic testing of neuromuscular transmission: facilitates electrophysiologic assessment of neuromuscular disorders.

How It Works

  • Neostigmine methylsulfate reversibly inhibits acetylcholinesterase at the neuromuscular junction, preventing breakdown of acetylcholine. The resulting increase in synaptic acetylcholine enhances cholinergic transmission, thereby improving muscle contraction and counteracting the effects of non‑depolarizing neuromuscular blockers.

Side Effects

Neostigmine methylsulfate may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Vomiting: occasional emesis following administration.
  • Increased salivation: excess oral secretions.
  • Sweating: generalized hyperhidrosis.
  • Abdominal cramps: transient colicky pain.
  • Muscle twitching: fasciculations of skeletal muscles.

Serious or Rare Side Effects

  • Bradycardia: clinically significant slowing of heart rate.
  • Bronchospasm: airway constriction leading to breathing difficulty.
  • Cholinergic crisis: excessive cholinergic activity causing muscle weakness.
  • Severe hypotension: marked drop in blood pressure.
  • Seizures: rare central nervous system excitation.
  • Allergic reactions: rash, urticaria, or anaphylaxis.

Precautions & Warnings

When using Neostigmine methylsulfate, clinicians should observe the following precautions:

  • Cardiac monitoring: patients with pre‑existing bradyarrhythmias require ECG surveillance.
  • Respiratory monitoring: watch for bronchospasm or increased secretions that may compromise airway.
  • Dose adjustment: reduce dose in patients with renal impairment due to decreased clearance.
  • Contraindications: avoid in individuals with known hypersensitivity to neostigmine or related compounds.
  • Pregnancy and lactation: safety data are insufficient; use only if clearly needed.
  • Store at ambient temperature: keep in original packaging, protect from moisture and light.

Avoid Interactions

Neostigmine methylsulfate can interact with several medicines; awareness of the interaction level is essential.

Major Interactions (Avoid)

  • Anticholinergic agents (e.g., atropine, scopolamine): antagonize therapeutic effect.
  • Beta‑blockers: may exacerbate bradycardia when combined.
  • Depolarizing neuromuscular blockers (e.g., succinylcholine): can prolong paralysis.

Moderate Interactions (Monitor Closely)

  • Inhalational anesthetics (e.g., sevoflurane): may enhance cholinergic side effects.
  • Other cholinesterase inhibitors (e.g., pyridostigmine): increase risk of cholinergic excess.
  • Aminoglycoside antibiotics: may potentiate neuromuscular weakness.
  • Magnesium sulfate: additive effect on neuromuscular transmission.
  • Cardiac glycosides (e.g., digoxin): heightened risk of arrhythmias.

Frequently Asked Questions

Neostigmine Methylsulfate is used to reverse the effects of non‑depolarizing neuromuscular blocking agents after surgery and as an adjunct treatment to improve muscle strength in patients with myasthenia gravis. It may also be employed in diagnostic tests that assess neuromuscular transmission.

The drug reversibly inhibits the enzyme acetylcholinesterase at the neuromuscular junction. By preventing the breakdown of acetylcholine, it increases the concentration of this neurotransmitter in the synaptic cleft, thereby enhancing cholinergic signaling and restoring muscle contraction.

The appropriate dose of Neostigmine Methylsulfate is determined by the prescribing clinician based on the patient’s weight, the type of neuromuscular blockade to be reversed, and clinical response. Dosage regimens are individualized and should follow the prescriber’s instructions.

Safety data for Neostigmine Methylsulfate in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Neostigmine Methylsulfate is a reversible anticholinesterase similar to pyridostigmine but is formulated for injectable use, allowing rapid onset for intra‑operative reversal of neuromuscular blockade. Compared with longer‑acting oral agents, it provides precise control in acute clinical settings.

The product should be stored at ambient temperature, below 25 °C, in its original sealed container. Protect it from moisture, direct sunlight, and extreme temperature fluctuations. Do not freeze; discard any solution that appears discolored or contains particles.

Neostigmine Methylsulfate is supplied as a sterile solution for intramuscular, intravenous, or subcutaneous injection. Administration is performed by a qualified healthcare professional, who selects the route and dose based on the clinical situation and monitors the patient for response and adverse effects.

Serious risks include bradycardia, bronchospasm, severe hypotension, cholinergic crisis, and rare allergic reactions such as anaphylaxis. Prompt recognition and management of these events are essential, and patients should be monitored closely during and after administration.

Neostigmine Methylsulfate is contraindicated in individuals with known hypersensitivity to neostigmine or any component of the formulation. Caution is also advised for patients with severe cardiac conduction disorders, uncontrolled asthma, or those taking interacting medications that could precipitate cholinergic excess.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Neostigmine Methylsulfate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT